Holen Sie sich die Stockscreener-App
23.12
0.99%
-0.23
Schlusskurs vom Vortag:
$23.35
Offen:
$23.67
24-Stunden-Volumen:
53,502
Relative Volume:
0.57
Marktkapitalisierung:
$1.42B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-143.59M
KGV:
-8.1881
EPS:
-2.8236
Netto-Cashflow:
$-119.47M
1W Leistung:
+3.68%
1M Leistung:
+0.00%
6M Leistung:
+40.21%
1J Leistung:
+26.96%
1-Tages-Spanne:
$22.86
$23.77
1-Wochen-Bereich:
$21.56
$24.01
52-Wochen-Spanne:
$11.51
$26.33
Pharvaris Nv Stock (PHVS) Company Profile
Vergleichen Sie PHVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHVS
Pharvaris Nv
|
23.12 | 1.42B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-11 | Eingeleitet | Guggenheim | Buy |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-09-25 | Eingeleitet | Wedbush | Outperform |
| 2023-08-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | Eingeleitet | Bryan Garnier | Buy |
| 2022-09-13 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2022-08-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-02 | Eingeleitet | BofA Securities | Neutral |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Pharvaris Nv Aktie (PHVS) Neueste Nachrichten
How institutional ownership impacts Pharvaris N.V. stockIPO Watch & Reliable Entry Point Alerts - Newser
Is Pharvaris N.V. stock bottoming out2025 Risk Factors & High Win Rate Trade Alerts - Newser
What Fibonacci levels say about Pharvaris N.V. reboundPortfolio Value Summary & Consistent Profit Trading Strategies - Newser
Real time pattern detection on Pharvaris N.V. stock2025 Volatility Report & Long-Term Growth Stock Strategies - Newser
Key resistance and support levels for Pharvaris N.V.2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - Newser
Resistance Break Could Fuel Pharvaris N.V. RallyJuly 2025 Opening Moves & Community Verified Trade Signals - mustnews.co.kr
Sector ETF performance correlation with Pharvaris N.V.Portfolio Risk Report & Fast Exit and Entry Trade Guides - Newser
Technical analysis overview for Pharvaris N.V. stockEarnings Overview Report & Stock Market Timing Techniques - Newser
Pharvaris Advances Clinical Pipeline with Strong Financials - TipRanks
Pharvaris N.V. stock momentum explainedWeekly Risk Summary & Safe Entry Momentum Stock Tips - Newser
When is the best time to exit Pharvaris N.V.July 2025 Review & Technical Buy Zone Confirmation - Newser
Pharvaris N.V. stock daily chart insightsMarket Trend Review & Growth Focused Stock Reports - Newser
Relative strength of Pharvaris N.V. in sector analysisBuy Signal & Accurate Entry and Exit Point Alerts - Newser
Smart tools for monitoring Pharvaris N.V.’s price actionGap Up & Free Technical Confirmation Trade Alerts - Newser
Does Pharvaris N.V. qualify in momentum factor screeningJuly 2025 Sentiment & Stock Portfolio Risk Management - Newser
Pharvaris N.V. Nearing Breakout Level After Bounce2025 Earnings Surprises & Daily Market Momentum Tracking - 선데이타임즈
Real time alert setup for Pharvaris N.V. performance2025 Analyst Calls & Capital Protection Trading Alerts - Newser
What is Leerink Partnrs’ Estimate for Pharvaris Q3 Earnings? - Defense World
Using data tools to time your Pharvaris N.V. exitTrade Entry Summary & Low Risk Entry Point Tips - Newser
Understanding Pharvaris N.V.’s price movementQuarterly Trade Report & High Conviction Investment Ideas - Newser
Can Pharvaris N.V. recover in the next quarterShort Setup & Real-Time Chart Breakout Alerts - Newser
Pharvaris N.V. stock outlook for YEARRisk Management & Free Community Consensus Stock Picks - Newser
Cantor Fitzgerald Lifts Earnings Estimates for Pharvaris - Defense World
Is Pharvaris N.V. a Top Dividend Stock to Watch in 2025July 2025 Spike Watch & Daily Oversold Bounce Ideas - Newser
Equities Analysts Issue Forecasts for Pharvaris Q3 Earnings - Defense World
BofA Securities Adjusts Price Target on Pharvaris to $16 From $14, Maintains Underperform Rating - MarketScreener
JMP Securities Issues Pessimistic Forecast for Pharvaris (NASDAQ:PHVS) Stock Price - Defense World
New Product Launches: Will They Boost Pharvaris N.V. Stock in 20252025 Top Gainers & Real-Time Market Trend Scan - Newser
JMP Securities Analyst Lowers PHVS Price Target to $52.00 - AInvest
Pharvaris: JMP Securities maintains Market Outperform, PT down to $52. - AInvest
Pharvaris stock price target lowered to $52 by Citizens JMP - Investing.com Nigeria
Tools to monitor Pharvaris N.V. recovery probabilityWeekly Profit Recap & Smart Allocation Stock Tips - Newser
Using portfolio simulators with Pharvaris N.V. includedDaily Upside Movement Prediction With Data - Newser
Finanzdaten der Pharvaris Nv-Aktie (PHVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):